Author

J. Flanagan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1

Frequent Co-Authors

A. J. Sabnis· 1 shared A. Tulpule· 1 shared A. Wiik· 1 shared B. Barad· 1 shared B. W. Newton· 1 shared C. H. Earnshaw· 1 shared D. P. Andersson· 1 shared E. Chan· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Sabnis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Muscle strength, size and composition following 12 months of gender-affirming treatment in transgender individuals: retained advantage for the transwomen

A. Wiik, T. R. Lundberg, E. Rullman, D. P. Andersson, M. Holmberg, M. Mandic, T. B. Brismar, O. Dahlqvist Leinhard, S. Chanpen, J. Flanagan, S. Arver, T. Gustafsson

This study examines how 12 months of gender-affirming hormone treatment affects muscle strength, size, and composition in transgender individuals, finding that transwomen retain an advantage in muscle mass and strength.

bioRxiv · Sep 26, 2019 · PreprintPhysiology

Synthetic essentiality of metabolic regulator PDHK1 in PTEN-deficient cells and cancers

N. Chatterjee, E. Pazarentzos, G. Hrustanovic, L. Lin, E. Verschueren, J. R. Johnson, M. Hofree, J. J. Yan, V. Olivas, B. W. Newton, J. V. Dollen, C. H. Earnshaw, J. Flanagan, E. Chan, S. Asthana, , T. G. Bivona

The paper identifies PDHK1 as a synthetic-essential gene in PTEN-deficient cells and cancers, showing its upregulation drives aerobic glycolysis and correlates with poor patient survival.

bioRxiv · Oct 11, 2018Cancer Biology